Throughout tumor progression, little is known regarding changes in the four major molecular subtypes of breast cancer, namely the luminal A, luminal B, human epidermal growth factor receptor 2-enriched (HER2-E), and basal-like subtypes [9,10,11,12,13,14,15,16,17]. Here, ERBB2 is linked to breast carcinoma.